Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial ; volume:14 ; number:1 ; day:15 ; month:9 ; year:2014 ; pages:1-6 ; date:12.2014
BMC cancer ; 14, Heft 1 (15.9.2014), 1-6, 12.2014
- Creator
-
Decaestecker, Karel
- Contributor
-
De Meerleer, Gert
Ameye, Filip
Fonteyne, Valerie
Lambert, Bieke
Joniau, Steven
Delrue, Louke
Billiet, Ignace
Duthoy, Wim
Junius, Sarah
Huysse, Wouter
Lumen, Nicolaas
Ost, Piet
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-671
- URN
-
urn:nbn:de:1111-2016030416181
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Decaestecker, Karel
- De Meerleer, Gert
- Ameye, Filip
- Fonteyne, Valerie
- Lambert, Bieke
- Joniau, Steven
- Delrue, Louke
- Billiet, Ignace
- Duthoy, Wim
- Junius, Sarah
- Huysse, Wouter
- Lumen, Nicolaas
- Ost, Piet
- SpringerLink (Online service)
Other Objects (12)
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study
Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study
Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
Oligometastasis and oligo-recurrence: more than a mirage
Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy
Metastasis-directed stereotactic body radiotherapy for oligometastatic renal cell carcinoma: extent of tumor burden eradicated by radiotherapy
Oligo-Aminoferrocenes For Cancer Treatment
Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study
Is Further Evaluation of Areas with Faint MDP Uptake Needed in Individuals with Oligo-Metastatic Prostatic Adenocarcinoma?
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligo-metastatic disease: an observational prospective multicentric study